Published in Medical Letter on the CDC and FDA, November 30th, 2003
These achievements included:
1) U.S. Food and Drug Administration (FDA) approval and launch of Ganite (gallium nitrate injection), Genta's first commercial product
3) Initiation of a "rolling" new drug application (NDA) submission to the FDA for Genasense in advanced malignant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA